Proliferating cells must generate both ATP and biosynthetic precursors for macromolecular synthesis. While proliferative signals have long been known to regulate metabolism, Garedew et al. now demonstrate that the proliferation apparatus itself, in the form of the ubiquitin ligase anaphase-promoting complex/cyclosome (APC/C), directly controls mitochondrial biogenesis, morphology, and respiratory activity.
The fields of cell division and metabolism are littered with an alphabet soup of factors, pathways, and intermediaries that ensure precise control. While many of the words comprising the languages of cell division and metabolism are known, the grammar of each remains poorly understood. Even more mysterious is the translating apparatus that enables information from one to make appropriate changes to the functioning of the other. In this issue of Cell Metabolism, Garedew and colleagues (Garedew et al., 2012) offer a bilingual lesson in cell proliferation and metabolism. They identify mitochondrial oxidative metabolism as a target of the cell-cycle ubiquitin ligase anaphasepromoting complex/cyclosome (APC/C). APC/C is an 12 subunit multiprotein ubiquitin ligase complex responsible for controlling cell-cycle progression through the regulated degradation of cyclins and other targets. Despite what the name would suggest, in different guises APC/C regulates transitions at many points in the cell cycle (Harper et al., 2002) . For example, in G1 APC/C restricts S phase entry until it is inactivated (Irniger and Nasmyth, 1997) . At the metaphase/ anaphase transition, APC/C not only promotes sister chromatid separation, but also induces degradation of M and S phase cyclins, preventing both entry into S phase and re-entry into mitosis. As cells pass the restriction point, G1 cyclins (which are not APC/C substrates) accumulate and form cdk/cyclin complexes that phosphorylate and inactivate the key G1 APC/C regulator Cdh1, thereby initiating S phase. In this way APC/C acts like the gears in a clock to enforce the correct temporal organization of the cell cycle.
The transition from quiescence to cell proliferation is typically accompanied by a host of metabolic changes. In T cells, for example, the proliferative burst observed following stimulation is associated with a dramatic increase in glycolysis (Frauwirth and Thompson, 2004) . Such a shift toward ATP production from aerobic glycolysis is now understood to be a fairly common feature of rapidly proliferating cells, especially cancer cells. Many investigators have assumed that this shift was a compensatory response to increased demand for energy and biosynthetic precursors. Work from the Moncada group, including the current study (Garedew et al., 2012) , however, has identified a number of APC/C substrates that directly enact metabolic changes. These include PFKFB3 and GLS1, enzymes involved in glycolysis and glutaminolysis, respectively (Almeida et al., 2010; Colombo et al., 2010; Tudzarova et al., 2011) , which become stabilized following mitogenic stimulation. In combination, this work suggests that at least some features of the proliferative metabolic program are direct consequences of proliferation and cell-cycle progression themselves. Now, Garedew et al. set out to investigate whether mitochondrial function is similarly coupled to proliferative signals through APC/C. Using two systems of stimulated proliferation, a serum starvation/refeeding regimen in primary MEFs and an anti-CD3/CD28 regimen to drive quiescent (G0) primary T cells into S phase, the authors found that both glycolysis (lactate production) and mitochondrial respiration were accelerated. The increase in respiration is correlated with increased mitochondrial protein and DNA content and articulation of the mitochondrial reticulum.
In an impressive set of experiments, the authors identified three new APC/C substrates that accumulate after triggering proliferation: OPA1 and MFN1 (involved in fusion of the mitochondrial inner and outer membranes, respectively) and TFAM (involved in mitochondrial transcription/replication). Each of these proteins contains APC/C target domains, known as destruction boxes and KEN boxes, which are required for their APC/C-dependent degradation. Using RNAi methodologies, the authors further show that OPA1 and TFAM are important for proliferation. These studies, mostly conducted with MEFs, demonstrate a coordinate regulation of mitochondrial fusion and biogenesis factors and progression into S phase through the APC/C. The work thus identifies a new pathway leading from proliferative signaling to enhanced mitochondrial biogenesis and function (Figure 1) . Perhaps more importantly, these findings provide a mechanism for restraining mitochondrial activity in quiescent cells.
While addressing the proliferation of MEFs and T cells, this work leaves the issue of other cell types unanswered. For example, unlike primary MEFs, proliferation of many cells requires specific cues in addition to nutrients and serum. Does stabilization of these newly identified targets require these additional cues? Many other questions also remain.
(1) Once cells are stimulated to emerge from G0, they can remain in a proliferative state. Taken at face value, one might assume that OPA1 and MFN1 exhibit cell-cycle-dependent oscillation.
This rather surprising implication remains to be evaluated experimentally. (2) How do the APC/C and proteasome gain access to OPA1, which is believed to be associated with the inner mitochondrial membrane and not in contact with the cytoplasm? Is mature OPA1 retrotranslocated to the cytosol and ubiquitinated? Alternatively, is nascent OPA1 ubiquitinated before entering the mitochondria? (3) Many cancer cells escape G1/S restriction. How might the observed coupling differ in oncogenically transformed cells? (4) The interplay between this pathway and nutrient/ oxygen availability also merits exploration, as cells in a malignant lesion may encounter conflicting signals, wherein the respiratory apparatus is induced but oxygen is not sufficient to support it. (5) How do these observations apply to embryonic and induced pluripotent stem cells, which, although highly proliferative, appear to strongly favor glycolysis and lactate production over respiration (Folmes et al., 2011)? This study might have general implications for the important topic of cancer metabolism. As Warburg described decades ago, cancer cells typically manifest glycolytic activity and lactate production in excess of expectation (Warburg et al., 1924) . This observation of Warburg has re-emerged recently and become a dominant theme in our understanding of cancer and the peculiar metabolic profile that cancer cells typically demonstrate. This preference for aerobic glycolysis has been misinterpreted by many as indicating that mitochondrial functions are expendable for cell proliferation, particularly in the context of cancer. Such a view is not consistent with the essential role played by mitochondria in the generation of many of the fundamental building blocks required to construct a new cell. This intriguing work by Garedew et al. has helped to remind us of these essential mitochondrial functions. Even under conditions when the majority of cellular ATP is a product of aerobic glycolysis, mitochondria still punctuate the language of cell proliferation. Cell-cycle oscillations are controlled through many signaling processes. One of these, the destruction of proteins by the APC/C, has now been shown to directly control metabolic behavior of the cell. Previously, the Moncada group showed that the APC/C complex targets key enzymes of glycolysis and glutaminolysis. In the present work, they show that the APC/C represses mitochondrial biogenesis and articulation through degradation of OPA1 and TFAM, thereby coupling proliferative signals directly with mitochondria (Garedew et al., 2012) .
